At a glance
- Originator Wyeth
- Class Antibacterials; Sulfones
- Mechanism of Action Beta lactamase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 20 Mar 2002 American Home Products and its subsidiary Wyeth-Ayerst are both now called Wyeth
- 20 Mar 2002 No development reported - Preclinical for Bacterial infections in USA (unspecified route)
- 20 Mar 2002 No development reported in Bacterial infections in USA